Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00027144 · ClinicalTrials.gov registry record · Phase 1
Study Using Vaccination With Heat Shock Protein 70 (HSP70) for the Treatment of CML in Chronic Phase
A Phase 1 study of Leukemia, Myeloid, Chronic and Leukemia,Myeloid,Philadelphia-Positive, sponsored by University of Connecticut.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT00027144: Completed Phase 1 study of Leukemia, Myeloid, Chronic and Leukemia,Myeloid,Philadelphia-Positive, sponsored by University of Connecticut.
NCT00027144 is a Phase 1 study of Leukemia, Myeloid, Chronic and Leukemia,Myeloid,Philadelphia-Positive that has completed, run by University of Connecticut. The registered enrollment target is 10 participants, below the 139-participant average among 3 other Leukemia, Myeloid, Chronic trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00027144, a Phase 1 study of Leukemia, Myeloid, Chronic and Leukemia,Myeloid,Philadelphia-Positive, has completed, sponsored by University of Connecticut.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
Description: The trial is designed to determine the response of the immune system of patients with CML to a vaccine made from their own tumor. Researchers believe that this particular vaccine, which is made from purified heat shock proteins taken from each patient's tumor, alerts the body's immune system to recognize and attack invading cancer. To be considered potentially eligible for this study you must have CML in the chronic phase. Length/Duration: Vaccinations will be administered weekly for eight weeks. One clinic follow up visit will be scheduled two weeks after the final vaccination.
Conditions Studied
Interventions
- BIOLOGICAL Heat Shock Protein 70 HSP70
Study Locations (1)
Connecticut
- University of Connecticut Health Center - Farmington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2000-12 |
| Est. Completion | 2002-10 |
| Phase | Phase 1 |
What the finished NCT00027144 record still lists
NCT00027144 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 139-participant average among 3 other Leukemia, Myeloid, Chronic trials with a reported enrollment target (93% lower).
The record links to 2 conditions, with Leukemia, Myeloid, Chronic appearing as the primary indexed condition, and to 1 intervention - of which Heat Shock Protein 70 HSP70 is the first listed.
NCT00027144 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT00027144 about?
NCT00027144 is a clinical study titled "Study Using Vaccination With Heat Shock Protein 70 (HSP70) for the Treatment of CML in Chronic Phase". Description: The trial is designed to determine the response of the immune system of patients with CML to a vaccine made from their own tumor. Researchers believe that this particular vaccine, which is made from purified heat shock proteins taken from each patient's tumor, alerts the body's immune s...
What is the current status of trial NCT00027144?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2000-12. Estimated completion is 2002-10.
What conditions does trial NCT00027144 study?
This clinical trial studies the following conditions: Leukemia, Myeloid, Chronic, Leukemia,Myeloid,Philadelphia-Positive.
What interventions are being tested in trial NCT00027144?
The interventions under investigation include: Heat Shock Protein 70 HSP70 (BIOLOGICAL).
Who is sponsoring clinical trial NCT00027144?
This trial is sponsored by University of Connecticut, which has 107 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00027144 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Leukemia, Myeloid, Chronic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
RECRUITING · Phase 1
-
Safety Assessment of Two Schedules of Intravenous Infusions of SNS-595 for the Treatment of Hematologic Malignancies
COMPLETED · Phase 1
-
Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia